Preview

Real-World Data & Evidence

Advanced search

Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”

https://doi.org/10.37489/2782-3784-myrwd-51

EDN: TJLIQC

Abstract

The European SocIn March 2024, the manual “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events” was published under general ed. Kolbin A. S. This textbook discusses biotechnological drugs from the perspective of clinical pharmacology. Basic definitions and classifications are given. Pharmacodynamics, phar­macokinetics and adverse events are reviewed. Examples of interactions between biotechnological drugs and small molecules are presented. A separate chapter examines the interchangeability of biological products — from basic terms and definitions of the concept of biosimilarity to regulatory aspects. The Appendix provides examples of clinical applications of therapeutic proteins. The manual is intended for students, residents, graduate students, clinical pharmacologists and physicians of other specialties.

About the Author

V. I. Petrov
Volgograd State Medical University
Russian Federation

Vladimir I. Petrov — DM, Professor, Academician of the Russian Academy of Sciences, President of the Volgograd State Medical University; head Department of  Clinical Pharmacology and Intensive Care; chief  freelance specialist — clinical pharmacologist of the  Russian Ministry of Health; President of the Association  of Clinical Pharmacologists 

Volgograd



Review

For citations:


Petrov V.I. Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”. Real-World Data & Evidence. 2024;4(1):66-68. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-51. EDN: TJLIQC

Views: 513


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2782-3784 (Online)